New Delhi, April 2 Emcure Pharmaceuticals announced on Thursday a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to improve patient access.The starting dose of Poviztra (0.25 mg) will now be available for Rs 3,999 per month...
New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...
New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...
New Delhi, February 27 Drug maker Abbott announced on Friday that it has partnered with Novo Nordisk India to commercialize Extensior, a second brand of Ozempic, for the treatment of type 2 diabetes in the country.The partnership leverages Novo Nordisk's scientific leadership in GLP-1s and...